Semler Scientific, Inc. (NASDAQ: SMLR) is a healthcare technology company specializing in innovative products for the early detection of chronic diseases, including its flagship FDA-cleared QuantaFlo® test for vascular health. In 2024, Semler became the second U.S. public company to adopt a Bitcoin treasury strategy, positioning Bitcoin as a strategic reserve asset to strengthen long-term growth alongside its healthcare mission.